Nutex Health Q2 earnings beat and cost cuts drive surge

 

Nutex Health Q2 earnings beat and cost cuts drive 16% surge

• Q2 net income swung to $65.8M (EPS $9.38) from prior-year loss; six-month net income surged 3100% to $112.6M (EPS $15.87).
• Massive $52.3M reduction in contract services expense from retroactive HaloMD agreement amendment and lower CMS fees boosted profits.
• Revenue normalized lower (Q2 -13.6% YoY to ~$211M) after 2025 IDR windfall, but hospital visits grew 9.6% YoY.
• Strong first-half operating cash flow reached $109.7M; ended period with $205M cash and low debt of $31M.
• Company reiterated plans to open three new micro-hospitals later in 2026, highlighting growth pipeline.
• Positive digestion of Aug 6 after-hours release and Aug 7 call continued into Aug 10 trading, lifting shares ~16% intraday.

https://finviz.com/stock?t=NUTX&p=d